Top Markets
#1 MowCat MowCat +280.67%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.75%
#3 Magma Finance Magma Finance +34.73%
#4 Cortex Cortex +26.36%
#5 DeXe DeXe +24.08%
#6 Akedo Akedo +22.69%
#7 SIXSEVEN SIXSEVEN +16.05%
#8 SODAX SODAX +14.20%
#9 OpenEden OpenEden +13.08%
#10 APEX APEX +12.01%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A

Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A

300026
Classement en actions #7663
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and... Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 and is headquartered in Tianjin, China.
Prix de l'action
$0.4999529
Capitalisation boursière
$1.50B
Changement (1 jour)
-0.86%
Changement (1 an)
-9.91%
Pays
CN
Échange Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (300026)

Catégorie

Healthcare
Ratio P/B pour Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (300026)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 2.4038 -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT